Revisiting the epidemiology of bloodstream infections and healthcare-associated episodes: results from a multicentre prospective cohort in Spain (PRO-BAC Study). Int J Antimicrob Agents. 2021 Jul;58(1):106352. doi: 10.1016/j.ijantimicag.2021.106352. Epub 2021 May 4. PMID: 33961992.
In vitro activity of ceftolozane-tazobactam and imipenem-relebactam against clinical isolates of Pseudomonas aeruginosa and Enterobacterales collected from haematology and oncology patients in a nationwide study in Spain (ACTHEON Study)
XXXI congreso ECCMID, 2021